Vectorborne Illnesses

Clinician Accuracy Evaluated for Lyme Disease

Clinician Accuracy Evaluated for Lyme Disease

Clinician suspicion shows limited accuracy in evaluating Lyme disease.

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

By

Without proactive measures and response, the changing climate is projected to continue to adversely affect the global incidence and distribution of infectious diseases and cause 250,000 additional deaths per year between 2030 and 2050.

When and How to Test for Lyme Disease, a Growing Threat

When and How to Test for Lyme Disease, a Growing Threat

Diagnosing Lyme disease can be difficult because symptoms vary from one person to another and can resemble symptoms of other infectious diseases spread by ticks.

Utah Resident Is First Zika-Linked Death in Continental United States

Utah Resident Is First Zika-Linked Death in Continental United States

Patient had an underlying medical condition and tested positive for Zika.

Outbreaks Shared Between US and Mexico Require Collaboration For Disease Management

Outbreaks Shared Between US and Mexico Require Collaboration For Disease Management

By

Because Aedes mosquitoes also transmit chikungunya and Zika viruses, there is risk for local transmission of these pathogens and a need for vector control and mosquito bite prevention strategies in the border region.

CDC Officials Update Diagnosis, Treatment Guidelines for Severe Tickborne Illnesses

CDC Officials Update Diagnosis, Treatment Guidelines for Severe Tickborne Illnesses

By

The guidelines note that physicians must request the correct diagnostic tests to confirm diagnosis, as well as completely understand the limitations and usefulness of these tests.

Mosquito Control Efforts Reducing Chikungunya Rates in Puerto Rico?

Mosquito Control Efforts Reducing Chikungunya Rates in Puerto Rico?

By

In addition to carrying chikungunya and dengue, female Aedes aegypti mosquitos also carry the Zika virus.

FDA Green Lights Medication For Rare Parasitic Disease

FDA Green Lights Medication For Rare Parasitic Disease

Profounda announced the launch of Impavido (miltefosine) for the treatment of visceral, mucosal, and cutaneous leishmaniasis in patients aged ≥12 years.

FDA Grants Tentative Approval to Tests of Gene-Modified Mosquitoes

FDA Grants Tentative Approval to Tests of Gene-Modified Mosquitoes

Agency says testing the insects in Florida Keys poses little risk to people, animals, the environment.

Sign Up for Free e-newsletters